• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar

NIDA IRP

National Institute on Drug Abuse - Intramural Research Program

  National Institute on Drug Abuse | NIH IRP | Treatment Info | Emergency Contacts
  • Home
  • News
    • Featured Paper of the Month
    • Reviews to Read
    • Hot off the Press
    • IRP News
    • Awards
    • Technology Development Initiative Paper of the Month
    • Seminar Series
    • Addiction Grand Rounds
  • About
    • About NIDA IRP
    • Contact Us
    • Directions and Map
    • Careers at NIDA IRP
    • Emergency Contacts
    • Employee Assistance Resources
  • Organization
    • Faculty
    • Office of the Scientific Director
    • Office of the Clinical Director
    • Office of Education and Career Development
    • Administrative Management Branch
    • Molecular Targets and Medications Discovery Branch
    • Cellular and Neurocomputational Systems Branch
    • Molecular Neuropsychiatry Research Branch
    • Neuroimaging Research Branch
    • Behavioral Neuroscience Research Branch
    • Integrative Neuroscience Research Branch
    • Translational Addiction Medicine Branch
    • Core Facilities
    • Community Outreach Group
  • Training Programs
    • Office of Education and Career Development
    • OECD Awards
    • Summer Internship Program
    • Postbaccalaureate Program
    • Graduate Partnership Program
    • Postdoctoral Program
    • NIDA Speakers Bureau
    • Clinical Electives Program
    • Clinical Mentoring Program
  • Study Volunteers

LE-Tg(EF1a-TetR)1Ottc

Last Updated on November 12, 2024

Background | Status & Availability | Transgene Info | Phenotypic Characterization | Breeding | Genotyping | References | Blog/Comments/Reviews | Related rats | Acknowledgements

Background

The tetracycline repressor (TetR) is a bacterial protein that binds to specific DNA elements referred to as Tet operator (TetO) sequences typically located in the promoter region of a gene of interest. In the absence of ligand, TetR binds TetO and represses transcription. Upon the addition of a ligand such as tetracycline or doxycycline, the repressor binding is removed and transcription occurs (Yao et al 1998 Hum Gene Ther).You are now exiting the NIDA IRP Website The LE-Tg(EF1a-TetR)1Ottc rat uses a ubiquitous promoter to express the TetR. The rat was designed to be combined with transgenic rats harboring TetO controlled transgenes but none are currently available. However, the rat can be combined with viral vectors containing the TetO DNA elements to repress transcription of a transgene until tetracycline or doxycycline is delivered.

Status and Availability

This strain has not yet been published.

As of May 17, 2016, this strain is available as line #00761 at the RRRC.You are now exiting the NIDA IRP Website

This rat is registered at the Rat Genome Database (RGD) as RGD ID# 9588587.You are now exiting the NIDA IRP Website

Transgene Information

Figure 1. Schematic of the EF1a-TetR transgene.Figure 1. Schematic of the EF1a-TetR transgene. The insert encoding a beta-globin intron and the open reading frame of TetR was amplified with linkered oligos and pENTR1A-TetR (Addgene #22265) as a template. This insert was recombined into the backbone pAAV EF1a DIO EYFP (Deisseroth Lab, Addgene #27056, digested with BamHI and EcoRI) using In-Fusion cloning mix (Clontech) to produce pAAV EF1a TetR (pOTTC338, Addgene #62194). The pOTTC338 plasmid was digested with MluI and RsrII, gel purified away from the plasmid backbone, and microinjected into fertilized oocytes harvested from a Long Evans rat by the NIMH Transgenic Core. Surviving pups were screened for the integrated transgene by PCR genotyping. This line (LE-Tg(EF1a-TetR)1Ottc) has 6 copies of the transgene per copy of Ggt1 (# copy per haploid genome) as determined by droplet digital PCR.

 

Phenotypic Characterization

Figure 2. Detection of TetR transgene expression in the rat brain.
Figure 2. Detection of TetR transgene expression in the rat brain. RIPA homogenates were produced from the cortex (CTX), striatum (STR), and substantia nigra (SN) of wildtype and transgenic rats, separated by polyacrylamide gel electrophoresis, and transferred to PDVF membranes. The blots were probed with anti-TetR clone 9G9 monoclonal antibody (Clontech Cat # 631131; green bands) and anti-Actin polyclonal antibody (Sigma Cat# A5060; red bands) then IR secondary antibodies were used for detection on the Li-Cor Odyssey. TetR2 corresponds to a different subline of the EF1a-TetR transgenic construct and is not available. Download print resolution version here.

 

Breeding Strategy

Breeding Information, click here for PDF

Genotyping Assays

Assay for presence of TetR, click here for PDF

References that cite this rat

No references are available at this time.

Blog/Comments/Reviews

Last Updated on November 12, 2024

No comments or reviews are available at this time.

Other related rats

No related rats at this time.

Acknowledgements

YaJun Zhang, Julie Necarsulmer, Chris Richie, Brandon Harvey, Janette Lebron

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Primary Sidebar

Transgenic Rats Project

  • Transgenic Rat Home
  • OTTC Information
  • Publications
  • Technology Development Initiative
  • Links

Organization

  • Organization
  • Faculty
  • Office of the Scientific Director
  • Office of the Clinical Director
  • Administrative Management Branch
  • Molecular Targets and Medications Discovery Branch
  • Cellular and Neurocomputational Systems Branch
  • Molecular Neuropsychiatry Research Branch
  • Neuroimaging Research Branch
  • Behavioral Neuroscience Research Branch
  • Integrative Neuroscience Research Branch
  • Translational Addiction Medicine Branch
  • Core Facilities
  • Careers at NIDA IRP
  • Technology Development Initiative
  • Community Outreach Group
Home / Organization / Office of the Scientific Director / Transgenic Rat Project / LE-Tg(EF1a-TetR)1Ottc
  • National Institute on Drug Abuse
  • NIH Intramural Research Program
  • National Institutes of Health
  • Health and Human Services
  • USA.GOV
  • Emergency Contacts
  • Employee Assistance
  • Treatment Information
  • Contact Us
  • Careers at NIDA IRP
  • Accessibility
  • Privacy
  • HHS Vulnerability Disclosure
  • Freedom of Information Act
  • Document Viewing Tools
  • Offsite Links
  • National Institute on Drug Abuse
  • NIH Intramural Research Program
  • National Institutes of Health
  • Health and Human Services
  • USA.GOV
  • Emergency Contacts
  • Employee Assistance
  • Treatment Information
  • Contact Us
  • Careers at NIDA IRP
  • Accessibility
  • Privacy
  • HHS Vulnerability Disclosure
  • Freedom of Information Act
  • Document Viewing Tools
  • Offsite Links

  • Home
  • News
    ▼
    • Featured Paper of the Month
    • Reviews to Read
    • Hot off the Press
    • IRP News
    • Awards
    • Technology Development Initiative Paper of the Month
    • Seminar Series
    • Addiction Grand Rounds
  • About
    ▼
    • About NIDA IRP
    • Contact Us
    • Directions and Map
    • Careers at NIDA IRP
    • Emergency Contacts
    • Employee Assistance Resources
  • Organization
    ▼
    • Faculty
    • Office of the Scientific Director
    • Office of the Clinical Director
    • Office of Education and Career Development
    • Administrative Management Branch
    • Molecular Targets and Medications Discovery Branch
    • Cellular and Neurocomputational Systems Branch
    • Molecular Neuropsychiatry Research Branch
    • Neuroimaging Research Branch
    • Behavioral Neuroscience Research Branch
    • Integrative Neuroscience Research Branch
    • Translational Addiction Medicine Branch
    • Core Facilities
    • Community Outreach Group
  • Training Programs
    ▼
    • Office of Education and Career Development
    • OECD Awards
    • Summer Internship Program
    • Postbaccalaureate Program
    • Graduate Partnership Program
    • Postdoctoral Program
    • NIDA Speakers Bureau
    • Clinical Electives Program
    • Clinical Mentoring Program
  • Study Volunteers